← Leaderboards
Kevin R King
Heprotech, Inc.
$6,236,576
Attributed
$6,697,866
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,697,866 · 9
By mechanism
DP2$2,355,000 · 1
R33$1,341,160 · 1
R01$765,288 · 1
R43$747,838 · 3
R00$745,663 · 1
R21$433,490 · 1
Top collaborators
- Suraj J Patel3 shared
- Andrew L Harris2 shared
- Raymond C Chan1 shared
- Raymond T Chung1 shared
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureSignal TransductionPreventSensorHeartCessation Of LifeBaseCellsGrantResponseCardiacCommunicationMediator Of Activation ProteinRecurrenceLungInjuryHourGap JunctionsInflammationPathogenesisAffectHospitalizationAcuteInhibitor/Antagonist
Grant awards (16)
Biological Mechanisms of the Infarct Borderzone$765,288
R01 · FY2025 · HL · contact PI
Advancement of an Impending Hospitalization Detection Platform$469,660
R33 · FY2025 · HL · contact PI
Advancement of an Impending Hospitalization Detection Platform$474,000
R33 · FY2024 · HL · contact PI
Advancement of an Impending Hospitalization Detection Platform$397,500
R33 · FY2024 · HL · contact PI
Non-contact In-Bed Sensing of Heart Failure Decompensation$223,612
R43 · FY2021 · HL
Noninvasive Adherence-independent Longitudinal Remote Chronic Disease Monitoring and Exacerbation Inference$197,240
R21 · FY2021 · NR · contact PI
Noninvasive Adherence-independent Longitudinal Remote Chronic Disease Monitoring and Exacerbation Inference$236,250
R21 · FY2020 · NR · contact PI
Danger Signaling and Spread of Injury after Myocardial Infarction$248,421
R00 · FY2019 · HL · contact PI
Elucidating Cell Communication Networks during Tissue Inflammation, Fibrosis, and Regeneration$2,355,000
DP2 · FY2018 · AR · contact PI
Danger Signaling and Spread of Injury after Myocardial Infarction$248,242
R00 · FY2018 · HL · contact PI
Danger Signaling and Spread of Injury after Myocardial Infarction$249,000
R00 · FY2017 · HL · contact PI
Danger Signaling and Spread of Injury after Myocardial Infarction$173,277
K99 · FY2016 · HL · contact PI
Danger Signaling and Spread of Injury after Myocardial Infarction$136,150
K99 · FY2015 · HL · contact PI
Development of Gap Junction Inhibition Therapy for Alcoholic Liver Disease$196,305
R43 · FY2014 · AA
Development of a hepatoprotective strategy for preventing drug-induced liver inju$167,514
R43 · FY2014 · DK
Development of a hepatoprotective strategy to prevent drug-induced liver injury$160,407
R43 · FY2013 · DK